TrianglePUBLICATIONS · 31227223
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Gynecol Oncol
- Publication date
- 2019 Sep
- First author
- Tang M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Tang M
- type
- Author
- name
- O'Connell RL
- type
- Author
- name
- Amant F
- type
- Author
- name
- Beale P
- type
- Author
- name
- McNally O
- type
- Author
- name
- Sjoquist KM
- type
- Author
- name
- Grant P
- type
- Author
- name
- Davis A
- type
- Author
- name
- Sykes P
- type
- Author
- name
- Mileshkin L
- type
- Author
- name
- Moujaber T
- type
- Author
- name
- Kennedy CJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Tang M
- type
- Author
- name
- O'Connell RL
- type
- Author
- name
- Amant F
- type
- Author
- name
- Beale P
- type
- Author
- name
- McNally O
- type
- Author
- name
- Sjoquist KM
- type
- Author
- name
- Grant P
- type
- Author
- name
- Davis A
- type
- Author
- name
- Sykes P
- type
- Author
- name
- Mileshkin L
- type
- Author
- name
- Moujaber T
- type
- Author
- name
- Kennedy CJ
- type
- Author
- bibliography ids
- nci-bib-2c0726ad17d8c56a7f871ae3
- book metadata
- content sha256
- ef7fba37a30717f05b955e8c6d56fe520927719e3dace7f7037f3c1d8d4459ef
- document type
- citation
- dois
- 10.1016/j.ygyno.2019.06.011
- electronic publication date
- display
- 2019 Jun 18
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31227223
- immutable id
- pubmed:31227223@ef7fba37a30717f05b955e8c6d56fe520927719e3dace7f7037f3c1d8d4459ef
- journal
- abbreviation
- Gynecol Oncol
- issn electronic
- 1095-6859
- issn print
- 0090-8258
- issue
- 3
- name
- Gynecologic oncology
- nlm unique id
- 0365304
- pages
- 531-538
- volume
- 154
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 31227223
- provenance
- batch id
- 23ffe1e2a9e160b6dca0
- provider
- NCBI PubMed ESummary
- record sha256
- b0964a3b1555be1fd860479c8a46b47192b568d62232365561e05effee5af699
- response sha256
- d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
- retrieved at
- 2026-09-09T23:47:44.690737+00:00
- publication date
- display
- 2019 Sep
- precision
- month
- year
- 2019
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Preserved source evidence · Not medical advice